PLASMA CELL MYELOMA
Clinical trials for PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for myeloma: 4-Drug cocktail aims to keep cancer at bay
Disease control Recruiting nowThis study tests whether adding a fourth drug (bortezomib) to a standard three-drug regimen (daratumumab, lenalidomide, dexamethasone) can better control multiple myeloma in people who are not eligible for early stem cell transplant. About 1,450 participants will be randomly assi…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New triple therapy aims to stop high-risk myeloma from coming back
Disease control Recruiting nowThis study tests whether a combination of three drugs—belantamab, pomalidomide, and dexamethasone—can keep high-risk myeloma from returning after a stem cell transplant. About 34 adults who have already had a transplant and are in partial remission or better will take these drugs…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New imaging agent aims to improve multiple myeloma detection
Diagnosis Recruiting nowThis early-stage study tests a new radioactive imaging agent called [89Zr]DFO-YS5 to see if it can safely and accurately detect multiple myeloma cells that have a specific protein (CD46). About 20 adults with confirmed multiple myeloma will receive the agent and undergo PET scans…
Matched conditions: PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: Robert Flavell, MD, PhD • Aim: Diagnosis
Last updated May 17, 2026 02:04 UTC
-
Simple lifestyle changes may improve myeloma outcomes, new study suggests
Symptom relief Recruiting nowThis study looks at whether non-drug approaches like physical activity, intermittent fasting, or adding a common beta-blocker (propranolol) can improve immune function and quality of life in people with multiple myeloma or related blood disorders. Researchers will measure changes…
Matched conditions: PLASMA CELL MYELOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated May 17, 2026 02:02 UTC
-
Brain radiation's hidden toll: new study tracks memory loss in blood cancer patients
Knowledge-focused Recruiting nowThis study follows 100 adults with blood cancers who receive whole brain radiation therapy to see how it affects their memory and thinking skills. Researchers will test cognitive function over time using standard assessments. The goal is to better understand the side effects of t…
Matched conditions: PLASMA CELL MYELOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:04 UTC